A radiomics model predicts progression from mild cognitive impairment to alzheimer's disease using structural MRI

Yifei Li1, Pengcheng Yi2, Mingmin Jin3

  • 1Department of Psychiatry, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

Scientific Reports
|October 13, 2025
PubMed

Insights

This study developed a machine learning model using MRI scans to predict mild cognitive impairment (MCI) progression to Alzheimer's disease (AD). The model accurately identifies high-risk individuals, aiding early intervention strategies for Alzheimer's disease.

Area of Science:

  • Neuroimaging
  • Machine Learning
  • Neurology

Background:

  • Mild cognitive impairment (MCI) is a precursor to Alzheimer's disease (AD).
  • Early prediction of MCI to AD progression is crucial for timely intervention.
  • Current prediction methods require enhancement for improved accuracy.

Purpose of the Study:

  • To develop and validate a predictive model for MCI to AD progression using structural MRI (sMRI).
  • To integrate radiomics features and clinical data for enhanced prediction accuracy.
  • To evaluate the model's diagnostic performance using ROC analysis.

Main Methods:

  • Utilized sMRI data from 343 MCI patients in the ADNI database.
  • Segmented T1-weighted images into gray and white matter; extracted radiomics signatures.
  • Constructed a prediction model combining radiomics and neuropsychological scores (CDR, ADAS-cog) using machine learning.

Main Results:

  • The integrated model demonstrated high predictive accuracy, with AUC values of 0.895 (training) and 0.882 (validation).
  • Clinical Dementia Rating (CDR), ADAS-cog, and radiomics markers were identified as independent predictors.
  • The comprehensive model showed significantly improved diagnostic efficacy compared to individual predictors (P=0.023).

Conclusions:

  • An sMRI-based integrated model can accurately predict MCI to AD progression.
  • This model identifies individuals at high risk, facilitating early diagnosis and management of Alzheimer's disease.
  • Radiomics analysis combined with clinical data offers a promising approach for neurodegenerative disease prediction.